Observational analysis evaluates erythropoiesis-stimulating agent therapy in maintenance hemodialysis, suggesting improved outcomes.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Masayuki Tanemoto (2026) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: